Education
About Us
Working with TipRanks
Follow Us
Nascent Biotech (NBIO)
:NBIO
NBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.19
Previous CloseN/A
Volume16.00K
Average Volume (3M)8.08K
Market Cap
$602.71K
Enterprise ValueN/A
Total Cash (Recent Filing)$1.82K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-4.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding172,202,160
10 Day Avg. Volume1,534
30 Day Avg. Volume8,078
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nascent Biotech News
PremiumCompany Announcements
Nascent Biotech Addresses OTC Filing Delinquency
---
Ownership Overview
20.30% Insiders
―
Mutual Funds
0.06% Other Institutional Investors
79.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NBIO FAQ
What was Nascent Biotech ’s price range in the past 12 months?
Nascent Biotech lowest stock price was $0.03 and its highest was $0.19 in the past 12 months.
What is Nascent Biotech ’s market cap?
Nascent Biotech ’s market cap is $602.71K.
When is Nascent Biotech ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nascent Biotech ’s earnings last quarter?
Currently, no data Available
Is Nascent Biotech overvalued?
According to Wall Street analysts Nascent Biotech ’s price is currently Overvalued.
Does Nascent Biotech pay dividends?
Nascent Biotech does not currently pay dividends.
What is Nascent Biotech ’s EPS estimate?
Nascent Biotech ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nascent Biotech have?
Nascent Biotech has 172,202,160 shares outstanding.
What happened to Nascent Biotech ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nascent Biotech ?
Currently, no hedge funds are holding shares in NBIO
---
Company Description
Nascent Biotech
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded in July 15, 2014 and is headquartered in San Diego, CA.
---
Technical Analysis
Cyclacel Pharmaceuticals
―
Ocugen
―
Anavex Life Sciences
―
Bioxcel Therapeutics
―
Aprea Therapeutics
―
---